Hexasodium phytate

Star0

DB18232InvestigationalSmall molecule

Hexasodium phytate: Overview.

Mechanism: Pharmacologically active on Hydroxyapatite
Curator reviewed
Formula / weight: C₆H₁₂Na₆O₂₄P₆ · 791.919 g/mol (avg)
Also known as: (1r,2r,3s,4s,5r,6s)-cyclohexane-1,2,3,4,5,6-hexayl-hexakis(dihydrogen phosphate) · Hexasodium fytate · Inositol, hexakis(dihydrogen phosphate) hexasodium salt, myo- · Myo-inositol, hexakis(dihydrogen phosphate), hexasodium salt
Code names: SNF-472

Resolves to

Compound

UNIIZBX50UG81VCAS34367-89-0

Clinical / RWD

RxNorm1730445

Structure

InChIKeyDHZIAGCFFSRULK-BQYPOXACSA-HSMILES

[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP([O-])(=O)O[C@H]1[C@H](OP(O)([O-])=O)[C@@H](OP(O)([O-])=O)[C@H](OP(O)([O-])=O)[C@H](OP(O)([O-])=O)[C@@H]1OP(O)([O-])=O

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Hexasodium phytate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account